Investigators, regulatory experts and drug developers involved in global anti-cancer drug development, particularly in examining populations or sub-populations in which drug development must be conducted internationally.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPrivacy policy